Clareo Health | Study on the Effects and Mechanisms of Modified Ma Xing Shi Gan Decoction in Treating Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine
Qingyang hospital of traditional Chinese medicine, Gansu Province
Traditional Chinese Medicine Hospital of Changji Hui Autonomous Prefecture, Xinjiang
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Patients meeting diagnostic criteria for COPD exacerbation, as defined by "Expert consensus on the acute exacerbation of chronic obstructive pulmonary disease in China (revision in 2023)" ;
2. Patients meeting the diagnostic criteria for phlegm-heat stagnation in the lungs syndrome within COPD, as referenced in the "Clinical Diagnosis and Treatment Terminology of Traditional Chinese Medicine: Syndromes" and the 2020 International Guidelines for Clinical Practice of Traditional Chinese Medicine;
3. Age \> 18 years;
4. Hospitalized patients;
5. Voluntarily consent to treatment and sign an informed consent form.
You may not be if
1. History of allergy to the study drug;
2. History of active liver disease;
3. Patients undergoing dialysis or with known moderate to severe renal impairment;
4. Suspected or confirmed active systemic infection;
5. Patients with host immune dysfunction, host immunodeficiency, or host immune reconstitution.
